Chemotherapy: Open Access
Open Access

Endo M

Publications

• Research Article
  Effect of Second-Line Chemotherapy in Elderly Patients with Non-Small Cell Lung Cancer
  Author(s): Kobayashi H, Kenmotsu H, Suzuki K, Omori S, Nakashima K, Wakuda K, Ono A, Naito T, Murakami H, Endo M, OhdeY and Takahashi T Kobayashi H, Kenmotsu H, Suzuki K, Omori S, Nakashima K, Wakuda K, Ono A, Naito T, Murakami H, Endo M, OhdeY and Takahashi T
  
  Background: The effect of second-line chemotherapy in patients with non-small cell lung cancer (NSCLC) who received first-line chemotherapy at the age of ≥ 75 years is unclear. Methods: Sixty-five elderly patients with NSCLC who received first-line chemotherapy at the age of ≥ 75 years and treated with second-line chemotherapy at Shizuoka Cancer Center between January 2005 and December 2014 were retrospectively reviewed. Results: The overall response rate of the second-line chemotherapy was 9.2% [95% confidence interval (CI) 4-19]. The median progression-free survival at the second-line chemotherapy was 2.2 months. The median overall survival at the second-line chemotherapy was 7.5 months. Multivariate analysis of prognostic factors showed that an Eastern Cooperative Oncology Group performance-status score (P.. View More»
  DOI: 10.4172/2167-7700.1000236

  Abstract PDF

Relevant Topics